STOCK TITAN

Amedisys Announces First Quarter 2022 Earnings Release and Conference Call Date

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Amedisys, Inc. (NASDAQ: AMED) will announce its first-quarter results for the period ending March 31, 2022, after market hours on April 27, 2022. The company plans to host an investor conference call the following day at 11:00 a.m. ET to discuss these results. Interested participants can join the call via toll-free numbers or through the company's website. Amedisys specializes in home health, hospice, personal care, and high-acuity care, serving over 445,000 patients annually with more than 11.5 million visits in 38 states.

Positive
  • None.
Negative
  • None.

BATON ROUGE, La., April 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the first quarter ended March 31, 2022, after the market closes on April 27, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on April 28, 2022.

To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (toll-free) or (412) 902-1028 (toll). A replay of the call will be available through May 28, 2022, by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and entering access ID 13729119.

A live webcast of the call will be accessible through the Company website on the Investor Relations section at https://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 90,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 549 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 445,000 patients in need every year, performing more than 11.5 million visits annually. For more information about the Company, please visit: www.amedisys.com.

Contact: 
Nick MuscatoKendra Kimmons
Amedisys, Inc.Amedisys, Inc.
Investor RelationsMedia Relations
615.928.5452225.299.3708
nick.muscato@amedisys.comKendra.kimmons@amedisys.com

FAQ

When will Amedisys report its first-quarter results for 2022?

Amedisys will report its first-quarter results after market close on April 27, 2022.

What time is the Amedisys investor conference call?

The investor conference call will be held at 11:00 a.m. ET on April 28, 2022.

How can I participate in the Amedisys conference call?

To participate, dial either 877-524-8416 (toll-free) or 412-902-1028 (toll) a few minutes before the call.

What services does Amedisys provide?

Amedisys provides home health, hospice, personal care, and high-acuity care services.

How many patients does Amedisys serve annually?

Amedisys serves more than 445,000 patients each year.

Amedisys Inc

NASDAQ:AMED

AMED Rankings

AMED Latest News

AMED Stock Data

2.75B
32.14M
2.38%
90.41%
6.66%
Medical Care Facilities
Services-home Health Care Services
Link
United States of America
BATON ROUGE